Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 13 | 2024 | 327 | 3.080 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2020 | 1323 | 1.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2020 | 1424 | 1.270 |
Why?
|
| Brain | 10 | 2020 | 949 | 1.090 |
Why?
|
| Artificial Intelligence | 3 | 2013 | 51 | 0.920 |
Why?
|
| Aged | 36 | 2024 | 10288 | 0.860 |
Why?
|
| Risk Assessment | 3 | 2018 | 1431 | 0.820 |
Why?
|
| Diet Therapy | 2 | 2020 | 15 | 0.750 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 58 | 0.670 |
Why?
|
| Databases, Factual | 2 | 2018 | 349 | 0.670 |
Why?
|
| Female | 40 | 2024 | 19859 | 0.630 |
Why?
|
| Humans | 50 | 2024 | 31836 | 0.620 |
Why?
|
| Exercise Therapy | 2 | 2020 | 268 | 0.610 |
Why?
|
| Oxygen | 2 | 2009 | 140 | 0.600 |
Why?
|
| Postmenopause | 5 | 2024 | 413 | 0.600 |
Why?
|
| Nerve Net | 2 | 2016 | 123 | 0.590 |
Why?
|
| Metabolomics | 3 | 2017 | 52 | 0.590 |
Why?
|
| Dementia | 4 | 2024 | 251 | 0.580 |
Why?
|
| Aged, 80 and over | 20 | 2024 | 3988 | 0.560 |
Why?
|
| Body Weight | 2 | 2020 | 306 | 0.530 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 125 | 0.530 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 125 | 0.510 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 1122 | 0.470 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 65 | 0.460 |
Why?
|
| Cerebrovascular Circulation | 3 | 2017 | 92 | 0.460 |
Why?
|
| Brain Mapping | 5 | 2011 | 178 | 0.450 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 63 | 0.450 |
Why?
|
| Women's Health | 6 | 2024 | 235 | 0.440 |
Why?
|
| Algorithms | 7 | 2020 | 495 | 0.440 |
Why?
|
| Male | 25 | 2024 | 19091 | 0.420 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 227 | 0.420 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 2271 | 0.380 |
Why?
|
| Middle Aged | 19 | 2024 | 11824 | 0.370 |
Why?
|
| Air Pollution | 2 | 2024 | 18 | 0.360 |
Why?
|
| Particulate Matter | 3 | 2024 | 31 | 0.360 |
Why?
|
| Cognition Disorders | 4 | 2019 | 384 | 0.360 |
Why?
|
| Cognition | 7 | 2024 | 551 | 0.350 |
Why?
|
| Estrogens | 1 | 2011 | 167 | 0.350 |
Why?
|
| Models, Theoretical | 2 | 2016 | 136 | 0.340 |
Why?
|
| Aging | 6 | 2024 | 941 | 0.330 |
Why?
|
| Behavior Therapy | 2 | 2020 | 102 | 0.320 |
Why?
|
| Hemodynamics | 1 | 2009 | 152 | 0.310 |
Why?
|
| Risk Factors | 10 | 2024 | 3851 | 0.310 |
Why?
|
| Hormone Replacement Therapy | 2 | 2019 | 88 | 0.290 |
Why?
|
| Aldosterone | 2 | 2017 | 26 | 0.280 |
Why?
|
| Models, Biological | 1 | 2009 | 391 | 0.280 |
Why?
|
| Exercise | 4 | 2021 | 663 | 0.280 |
Why?
|
| Life Style | 2 | 2020 | 407 | 0.280 |
Why?
|
| Longitudinal Studies | 6 | 2020 | 771 | 0.280 |
Why?
|
| Incidence | 6 | 2024 | 1192 | 0.270 |
Why?
|
| Memory Disorders | 2 | 2018 | 54 | 0.270 |
Why?
|
| Renin | 2 | 2017 | 109 | 0.270 |
Why?
|
| Software | 1 | 2006 | 127 | 0.270 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 549 | 0.270 |
Why?
|
| Proteomics | 2 | 2024 | 94 | 0.260 |
Why?
|
| Geriatric Assessment | 2 | 2018 | 390 | 0.260 |
Why?
|
| Environmental Exposure | 3 | 2024 | 90 | 0.250 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2016 | 128 | 0.250 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 21 | 0.240 |
Why?
|
| Wrist | 2 | 2021 | 48 | 0.240 |
Why?
|
| Tomography | 1 | 2004 | 4 | 0.240 |
Why?
|
| Magnetics | 1 | 2004 | 5 | 0.240 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 104 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 23 | 0.230 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 74 | 0.230 |
Why?
|
| Weight Loss | 2 | 2017 | 465 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 104 | 0.220 |
Why?
|
| Insulin Resistance | 2 | 2017 | 461 | 0.220 |
Why?
|
| DNA Methylation | 1 | 2024 | 140 | 0.220 |
Why?
|
| Computer Simulation | 4 | 2009 | 220 | 0.220 |
Why?
|
| Inflammation | 4 | 2024 | 540 | 0.210 |
Why?
|
| African Americans | 4 | 2017 | 1428 | 0.210 |
Why?
|
| Baltimore | 3 | 2018 | 50 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2024 | 1824 | 0.210 |
Why?
|
| Phenotype | 1 | 2024 | 635 | 0.210 |
Why?
|
| Adult | 12 | 2021 | 9327 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 835 | 0.200 |
Why?
|
| Blood Pressure | 2 | 2024 | 843 | 0.200 |
Why?
|
| Young Adult | 8 | 2021 | 2603 | 0.190 |
Why?
|
| Logistic Models | 2 | 2013 | 777 | 0.190 |
Why?
|
| Depression | 1 | 2024 | 442 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 398 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 73 | 0.180 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 764 | 0.180 |
Why?
|
| Brain Ischemia | 2 | 2012 | 145 | 0.170 |
Why?
|
| Health Care Costs | 1 | 2020 | 117 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 409 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 239 | 0.170 |
Why?
|
| Medicare | 1 | 2020 | 206 | 0.170 |
Why?
|
| Coronary Disease | 2 | 2017 | 213 | 0.160 |
Why?
|
| Electronic Health Records | 1 | 2020 | 159 | 0.160 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 81 | 0.160 |
Why?
|
| Disease Progression | 2 | 2018 | 593 | 0.160 |
Why?
|
| Auditory Cortex | 2 | 2009 | 21 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 147 | 0.160 |
Why?
|
| Visual Cortex | 2 | 2009 | 35 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2019 | 177 | 0.160 |
Why?
|
| Blood | 1 | 2018 | 10 | 0.160 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 22 | 0.150 |
Why?
|
| Models, Psychological | 1 | 2018 | 24 | 0.150 |
Why?
|
| Mass Screening | 1 | 2020 | 263 | 0.150 |
Why?
|
| Metabolome | 1 | 2018 | 36 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2024 | 767 | 0.150 |
Why?
|
| Auditory Perception | 2 | 2009 | 80 | 0.150 |
Why?
|
| Lipids | 1 | 2019 | 228 | 0.150 |
Why?
|
| Cholesterol | 1 | 2019 | 251 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 1527 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 19 | 0.150 |
Why?
|
| Visual Perception | 2 | 2009 | 116 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 18 | 0.140 |
Why?
|
| Neoplasms | 1 | 2024 | 692 | 0.140 |
Why?
|
| alpha-Macroglobulins | 1 | 2016 | 3 | 0.140 |
Why?
|
| Phospholipids | 1 | 2017 | 28 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 157 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2016 | 59 | 0.140 |
Why?
|
| Anthropometry | 1 | 2016 | 83 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2016 | 90 | 0.140 |
Why?
|
| Demography | 1 | 2016 | 110 | 0.140 |
Why?
|
| Glucose | 1 | 2017 | 173 | 0.140 |
Why?
|
| Leptin | 1 | 2016 | 71 | 0.140 |
Why?
|
| Radiography | 2 | 2016 | 376 | 0.140 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 177 | 0.130 |
Why?
|
| Adiponectin | 1 | 2016 | 106 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 53 | 0.130 |
Why?
|
| Triglycerides | 1 | 2016 | 230 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 70 | 0.130 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 8 | 0.120 |
Why?
|
| Stroke | 2 | 2017 | 581 | 0.120 |
Why?
|
| Diet | 1 | 2017 | 385 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 89 | 0.120 |
Why?
|
| Decision Trees | 1 | 2014 | 31 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 178 | 0.120 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 94 | 0.120 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 187 | 0.120 |
Why?
|
| Prognosis | 1 | 2018 | 1498 | 0.120 |
Why?
|
| ROC Curve | 1 | 2014 | 167 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2016 | 491 | 0.120 |
Why?
|
| United States | 5 | 2020 | 3925 | 0.110 |
Why?
|
| Time Factors | 1 | 2018 | 2146 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 68 | 0.110 |
Why?
|
| Retinal Vessels | 1 | 2012 | 19 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2020 | 2277 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2012 | 20 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 449 | 0.100 |
Why?
|
| Horses | 1 | 2011 | 13 | 0.100 |
Why?
|
| Attention | 2 | 2009 | 83 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2011 | 38 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2011 | 72 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2011 | 113 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2011 | 117 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1158 | 0.090 |
Why?
|
| Energy Metabolism | 2 | 2021 | 148 | 0.090 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 686 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 34 | 0.080 |
Why?
|
| Organ Size | 3 | 2016 | 208 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2008 | 12 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 257 | 0.080 |
Why?
|
| Neural Inhibition | 1 | 2008 | 28 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2008 | 79 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 29 | 0.070 |
Why?
|
| tau Proteins | 2 | 2017 | 41 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 132 | 0.070 |
Why?
|
| Risk | 2 | 2019 | 318 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2006 | 107 | 0.070 |
Why?
|
| Heterozygote | 1 | 2024 | 57 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 3511 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2024 | 57 | 0.060 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 26 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2024 | 94 | 0.060 |
Why?
|
| Artifacts | 1 | 2004 | 39 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2017 | 916 | 0.060 |
Why?
|
| Mortality | 1 | 2024 | 124 | 0.060 |
Why?
|
| Medicare Part A | 1 | 2020 | 5 | 0.050 |
Why?
|
| Medicare Part B | 1 | 2020 | 5 | 0.050 |
Why?
|
| Wrist Joint | 1 | 2021 | 60 | 0.050 |
Why?
|
| Medicare Part D | 1 | 2020 | 8 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2020 | 17 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2024 | 687 | 0.050 |
Why?
|
| Health Services | 1 | 2020 | 38 | 0.050 |
Why?
|
| Age of Onset | 1 | 2020 | 93 | 0.040 |
Why?
|
| Counseling | 1 | 2020 | 97 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2020 | 66 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 238 | 0.040 |
Why?
|
| Apolipoprotein C-I | 1 | 2019 | 4 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2019 | 13 | 0.040 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 370 | 0.040 |
Why?
|
| Animals | 1 | 2011 | 7450 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 37 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 251 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 144 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Problem Solving | 1 | 2018 | 28 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 874 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 463 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2017 | 7 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2017 | 18 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2017 | 57 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 21 | 0.040 |
Why?
|
| Acoustic Stimulation | 2 | 2009 | 126 | 0.040 |
Why?
|
| Thiazoles | 1 | 2017 | 27 | 0.040 |
Why?
|
| Sleep | 1 | 2018 | 92 | 0.040 |
Why?
|
| Calcineurin | 1 | 2016 | 3 | 0.040 |
Why?
|
| Sample Size | 1 | 2017 | 39 | 0.040 |
Why?
|
| Hypertension | 1 | 2024 | 956 | 0.040 |
Why?
|
| Amino Acids | 1 | 2017 | 46 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 471 | 0.040 |
Why?
|
| Fasting | 1 | 2017 | 95 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 99 | 0.040 |
Why?
|
| Prevalence | 1 | 2019 | 979 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 238 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 195 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 191 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 74 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 230 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 147 | 0.030 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 15 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 310 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 271 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 397 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 756 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 90 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 226 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 662 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 1067 | 0.030 |
Why?
|
| Knee Joint | 1 | 2016 | 142 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 398 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 493 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 480 | 0.030 |
Why?
|
| Neurons | 1 | 2016 | 409 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 504 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 924 | 0.030 |
Why?
|
| Reference Values | 1 | 2011 | 247 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 461 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2009 | 158 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2008 | 13 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 56 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3294 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 94 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 80 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 51 | 0.020 |
Why?
|
| Movement | 1 | 2006 | 50 | 0.020 |
Why?
|
| Fingers | 1 | 2006 | 64 | 0.020 |
Why?
|